COVID-19 forecasting and intervention planning using gated recurrent unit and evolutionary algorithm.
COVID-19 prediction
Differential evolution (DE)
Gated recurrent unit (GRU)
Multi-population evolutionary algorithm
Policy prescription
Journal
Neural computing & applications
ISSN: 0941-0643
Titre abrégé: Neural Comput Appl
Pays: England
ID NLM: 9313239
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
09
2021
accepted:
03
05
2022
pubmed:
8
6
2022
medline:
8
6
2022
entrez:
7
6
2022
Statut:
ppublish
Résumé
The rapid spread of COVID-19, caused by the SARS-CoV-2 virus, has had and continues to pose a significant threat to global health. We propose a predictive model based on the gated recurrent unit (GRU) that investigates the influence of non-pharmaceutical interventions (NPIs) on the progression of COVID-19. The proposed model is validated by case studies for multiple states in the United States. It should be noted that the proposed model can be generalized to other regions of interest. The results show that the predictive model can achieve accurate forecasts across the US. The forecast is then utilized to identify the optimal mitigation policies. The goal is to identify the best stringency level for each policy that can minimize the total number of new COVID-19 cases while minimizing the mitigation costs. A meta-heuristics method, named multi-population evolutionary algorithm with differential evolution (MPEA-DE), has been developed to identify optimal mitigation strategies that minimize COVID-19 infection cases while reducing economic and other negative implications. We compared the optimal mitigation strategies identified by the MPEA-DE model with three baseline search strategies. The results show that MPEA-DE performs better than other baseline models based on prescription dominance.
Identifiants
pubmed: 35669538
doi: 10.1007/s00521-022-07394-z
pii: 7394
pmc: PMC9153241
doi:
Types de publication
Journal Article
Langues
eng
Pagination
17561-17579Informations de copyright
© The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2022.
Déclaration de conflit d'intérêts
Conflict of interestThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
PLoS One. 2022 Jan 28;17(1):e0262708
pubmed: 35089976
PLoS One. 2018 Dec 21;13(12):e0207777
pubmed: 30576319
Nat Hum Behav. 2021 Jul;5(7):947-953
pubmed: 33972767
Front Artif Intell. 2020 May 22;3:41
pubmed: 33733158
Transbound Emerg Dis. 2020 Mar;67(2):935-946
pubmed: 31738013